Biomedical Bonding’s AdhFix featured as a cover page of Wiley’s Advanced Functional Material journal
News: Biomedical Bonding’s AdhFix treatment of bone fractures has been chosen as a cover by the publisher Wiley for their journal – Advanced Functional Materials. AdhFix is a patient personalized surgical treatment for the fixation of complex fractures that exclude the use of rigid metal plates.
AdhFix is an innovative fracture fixation method that landed a spot as a cover page of the highly coveted Wiley Journal – Advanced Functional Materials. The scientific article titled “Highly Customizable Bone Fracture Fixation through the Marriage of Composites and Screws” is now available online for viewing (https://onlinelibrary.wiley.com/doi/10.1002/adfm.202170302). The publication will give you an insight on a new bone fracture fixation treatment that can replace metal plates with composite fixators that are created by the surgeons during the fixation of fractures. Led by Professor Michael Malkoch (right) and co-authors Viktor Granskog and Daniel John Hutchinson (from left respectively).
For more information, please contact:
Michael Malkoch, CEO and Founder
Phone: +46 (0) 8 121 56 755
Biomedical Bonding AB is a platform based Swedish MedTech company that develops cutting-edge medical adhesive fixators and novel surgical methodologies with focus on the ever-growing market of hard tissue restorations. The technological platform, Bonevolent™, is market disruptive and stands for a paradigm shift in personalized surgical interventions. BMB´s vision is to become the dominant global provider of unique adhesive products suited for fracture fixation and dental restoration market. BMB´s Bonevolent™ products are easy-to-use by clinicians, will increase patient safety, save costs and resources for health care and society as a whole. BMB is a privately held company headquartered in Stockholm, Sweden.